KITLG and cardiac hypertrophy: Atrogin-1 interacts with calcineurin A in cardiac myofibril and together with SCF complex it polyubiquitinates and degrades the calcineurin A leading to the inhibition of cardiac hypertrophy (Wertz et al., 2004).